The "Catch-Up" of 2026
The 8% hike isn't just about today’s inflation; it’s a "catch-up" phase for the industry.
The Rebuilding Gap: While general inflation has...
The End of the "Telemedicine Cliff"
After several brief lapses in late 2025 and early 2026, the federal government has provided long-term certainty for patients...
The "Single Consent" Revolution
Before 2026, sharing substance use disorder (SUD) records required a separate, specific signed consent for every single doctor or insurance claim.
The...
The "First 10" Negotiated List (2026)
The Centers for Medicare & Medicaid Services (CMS) selected these drugs based on high total spending and the absence...
The Permanent $35 Protection
The landmark $35 monthly cap on insulin, which began in 2023, is now a permanent fixture of the Medicare landscape.
Day-One Savings:...
The "Rebate" Engine Driving $0 Costs
The secret behind the $0 premium isn't that the insurance is free; it’s how the government pays the insurers.
The...
The 2026 Shift—From Engagement to "Claims Impact"
In 2026, HR departments have moved away from "usage rates" (how many people logged in) to Claims Correlation.
The...
The New "Covered Service Provider" Status
The 2026 CAA formally reclassified Pharmacy Benefit Managers (PBMs) as "covered service providers" under ERISA.
The Impact: This forces PBMs...
The "Reference-Based Pricing" (RBP) Shield
In 2026, the most effective way to slash premiums is to abandon the "Negotiated Rate" model.
The Strategy: RBP drops traditional...
